Description
Diapride M1 LV Tablet SR
Composition: Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Category: Anti-diabetic combination drug
Used for: Type 2 Diabetes Mellitus in adults.
Key Benefits:
Controls post-meal blood sugar spikes (voglibose slows carbohydrate breakdown).
Improves insulin sensitivity (metformin) and stimulates insulin release (glimepiride).
Reduces cardiovascular risks in diabetic patients with existing heart conditions.
Dosage & Administration:
Take once daily with food (to avoid stomach upset).
Swallow whole; do not crush/chew (SR tablet).
Missed dose: Take ASAP, but skip if close to next dose.
Common Side Effects:
Hypoglycemia (sweating, dizziness, hunger) – Carry sugary snacks.
Nausea, diarrhea, abdominal pain.
Weight gain (possible with glimepiride).
Serious Warnings:
Avoid in:
Type 1 diabetes, diabetic ketoacidosis.
Severe kidney/liver disease.
Pregnancy/breastfeeding (consult doctor).
Alcohol: Unsafe (increases hypoglycemia risk).
Driving: Caution due to dizziness from low/high blood sugar.
Lifestyle Tips:
Combine with diet, exercise, and weight management.
Monitor blood sugar regularly.
Why Continue Treatment?
Stopping abruptly can raise blood sugar, increasing risks of kidney damage, nerve problems, and blindness.
Note: Always follow your doctor’s advice on dosage adjustments and monitoring.







Reviews
There are no reviews yet.